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Objective: During pulmonary resections for non–small cell lung cancer, the pulmo-
nary vein is traditionally interrupted first to prevent seeding of malignant cells and
consequently decrease metastatic implantation. This hypothesis was never con-
firmed scientifically. The aim of the present study was to determine whether the
sequence of vessel interruption during lobectomy (lobar vein or lobar artery first)
affects disease recurrence.
Methods: A historical prospective study was performed of 279 consecutive patients
with complete follow-up, who survived lobectomy for non–small cell lung cancer
during 1992 to 1998, in a single center. Pre-, intra-, and postoperative variables were
collected from the medical records; recurrence and vital status were obtained from
follow-up files, central population registry, and personal confirmation, updated to
December 2000. Comparison of recurrence rates by sequence of ligation and other
independent variables was assessed by univariate and multivariate logistic regres-
sion analyses.
Results: A total of 133 patients (48%) had vein interruption before the artery
(V-first) and 146 (52%) had artery interruption first (A-first). The distribution of
demographic, clinical, and other characteristics was similar between the 2 groups,
except for the operated side and performing surgeons. The morbidity, blood re-
quirement, and length of stay were equal for both groups. The total recurrence rate
(A-first, 53%; V-first, 51%) was similar. Multivariate analysis (controlling for the
effect of the performing surgeon) revealed elevated risk for recurrence among
patients with high disease stage (odds ratio  2.54), male gender (odds ratio 
1.59), intraoperative lung manipulation (odds ratio  2.72), and blood transfusion
(odds ratio  1.49). Sequence of vessel interruption was not found as a risk factor
for recurrence (odds ratio  1.29; 95% 0.73 to 2.29, P  .4).
Conclusions: Our results did not show that sequence of vessel interruption during lobec-
tomy plays a role in tumor recurrence. A prospective study with randomization in selection
of method as well as surgeons for each patient is needed to confirm these results.
Although many new treatment modalities have been proposed re-cently to improve survival of patients with non–small cell lungcancer (NSCLC), surgery and complete removal of the primarytumor and its involved lymph nodes remains the most effectivetreatment for these patients.1 The basic technique for lobectomy,the most common type of resection, did not change since the
1940s when individual hilar dissection evolved.2,3 During the years there were
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changing fashions regarding the sequence of vessel inter-
ruption (lobar veins first and arteries to be followed or vise
versa). Today’s standpoint is much more liberal and the
recommendation is that the order of vessel dissection and
division will be according to the surgeon’s preference.4
Theoretically, manipulation of the lung during operation
can produce spillage of tumor cells into the circulation and
seeding of micrometastasis to distant organs. Therefore,
interruption of the lobar vein before ligation of the artery
may be justified. Lobar artery interruption first, on the other
hand, may have an advantage in preventing unnecessary
blood loss as the blood supply to the lobe is immediately
closed. Several studies support vein interruption before ar-
tery. One experimental study on animals5 showed that sur-
gical manipulation of tumors evokes enhancement of me-
tastases. In another study,6 higher levels of tumor marker
were found in the peripheral blood of patients with NSCLC
who underwent lobectomy in an artery-to-vein sequence
compared with those with a vein-to-artery sequence. The
claim that interruption of the artery before the vein may
lessen the blood loss during surgery was rejected by Miller
and colleagues7 in an animal study. Practical implications
on prognosis, determined by the sequence of the procedure,
remain unsolved.
Interestingly, the issue whether surgical manipulation
affects prognosis has gained growing attention recently
since the introduction of the video-assisted (VATS) lobec-
tomy. One of the arguments against VATS lobectomy for
lung cancer is that the forceful retraction of the lung, which
is necessary to achieve clear video visualization during this
procedure, may increase the risk of tumor cell dissemination
and therefore affect the patient’s prognosis.8
The aim of the present report was to examine the possible
effect of sequence of vessel interruption (lobar vein first
versus lobar artery first) on prognosis in patients undergoing
lobectomy for NSCLC.
Materials and Methods
From January 1992 to December 1998, 307 patients underwent
lobectomy for NSCLC in the Chaim Sheba Medical center. Of
these, 10 patients were excluded from this analysis due to mixed
order of vessels interruption during the lobectomy, 12 patients
were excluded due to perioperative death (defined as death within
30 days after surgery or at any time if the patient was never
discharged from the hospital), and 6 other patients were excluded
because they were lost to follow-up. These last 6 patients are all
alive according to the Israeli central population registry but their
disease status is unknown. Thus, 279 patients (90.9% of the target
population) were included in this study. Of them, 133 (48%)
underwent interruption of pulmonary vein before artery (designat-
ed “V-first”) and 146 (52%) underwent interruption of pulmonary
artery first (designated “A-first”). The decision of which method to
use in each operation was based on the discretion of the operating
surgeon.
Demographic, preoperative, intraoperative, postoperative, and
histologic data was collected by a retrospective review of the
medical records. Disease status (ie, free from disease or recur-
rence) was updated from outpatient clinic records and telephone
survey for all uncertain conditions. Vital status was updated via the
Israeli’s Central Population Registry.
Preoperative evaluation included smoking and medical history,
previous malignancies, previous operations on the chest, labora-
tory tests, pulmonary function tests, and imaging evaluation. Op-
erative data included presence of pleural adhesions, obtainment of
frozen section before resection, types of lobectomy, sequence of
vessel interruption, and additional resections performed during this
procedure. Cases in which significant lung retraction was neces-
sary before proceeding with lobar resection (en bloc chest wall
resection before hilar dissection and management of severe adhe-
sions) were also recorded and designated as “lung manipulation.”
Completeness of resection was defined as free peripheral and hilar
margins and negative lymph node in the higher station sampled.
Histologic data and pathologic staging according to the interna-
tional lung cancer staging system9 were also recorded. For 38
patients who received preoperative treatment (mainly neoadjuvant
chemotherapy) the preoperative clinicohistological stage of dis-
ease was used. Postoperative complications were categorized as
medical (eg, fever, pneumonia) and technical complications (eg,
air leak). Use of blood transfusion and length of hospital stay were
also recorded.
All patients were followed until death, recurrence, or study
termination on December 2000, whichever came first. Mean fol-
low up was 22.6 months (range 0.16-106 months). The end point
of the present study was defined as recurrence. This dependent
variable was categorized in two groups: “recurrence” (considered
as death from the disease or staying alive with a diagnosed disease)
and “nonrecurrent” (all patients who were alive without disease or
died from other illness).
Statistical Analysis
All statistical analysis was done with SAS software (SAS, Inc,
Cary, NC). Statistical significance for difference between the two
treatments groups (V-first and A-first) for each continuous variable
was evaluated by means of a 1-way analysis of variance. Compar-
ison of categorical variables between the 2 groups was performed
by the -square test or the Fisher exact test according to the cell
size examined. A correlation matrix was used to examine possible
association between completeness of resection and stage of dis-
ease, between performing surgeon and stage. A logistic multivar-
iate analysis was performed to determine whether the method of
surgery (sequence of vessel interruption) had an impact on recur-
rence of the disease, controlling for the known and significant
factors for recurrence. We first estimated the risk of recurrence for
sequence of interruption, introduced the stage of disease, then
included performing surgeon, and investigated the interaction be-
tween sequence of interruption and performing surgeon. Finally,
we entered the remaining factors that were found to be associated
with recurrence in the univariate analysis: gender, lung manipula-
tion, and blood transfusion. This step-by-step process enabled us to
determine whether the effect of sequence of interruption was
changed by the above-mentioned covariates.
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Results
Demographic- and Tumor-Related Variables
The mean age of the study population was 65.1 (10) years.
Male/female ratio was 1.7 (63% men and 37% women).
There were no significant differences between the V-first
group and the A-first group in respect to all demographic
variables such as age, sex, and smoking history (Table 1).
No statistically significant differences were found be-
tween the groups regarding the percent of patients having
50% or more than the predicted forced expiratory volume in
1 second as well as in forced vital capacity (not shown).
Table 1 also includes tumor-related variables such as
tumor type, grade, and stage. Adenocarcinoma was the most
common histologic diagnosis in both groups, accounting for
54.1% of all tumors (60.3% among the A-first group and
47.4% among the V-first group, P  .04). Squamous cell
carcinoma was the second most common tumor (29.7%).
Mixed type and unspecified NSCLC were combined in the
same category and designated as “others.” A large propor-
tion of the patients were diagnosed at stage I (54.5%), again
with similarity in the 2 groups. No significant differences in
the distribution of the 2 study groups by grade or by pre-
vious malignancy were observed.
Operative Approach Characteristics
As was stated before, all patients underwent lobectomy, but
66 patients (23.7%) had additional resections in the same
session such as sleeve, pericardium, wedge of lung, pleura,
or diaphragm (Table 2). Ten (15%) of them had 2 additional
resections. There was no significant difference between the
2 study groups regarding the additional resections but
wedge resection was significantly more prevalent in the
A-first group (10.3%) compared with the patients in the
V-first group(3.8%). Right-sided resection and hence tumor
location was significantly more prevalent in the V-first
group (Table 2). Complete resection was performed on 81%
with no difference between the 2 study groups. There was
no significant difference between the 2 study groups in
obtaining frozen section before proceeding with lobar
resection. Performance of lung manipulation was more
common in the A-first group (10.3% versus 4.5%) (P 
.07).
Strong correlation was found between the surgeon and
the sequence of interruption that was used (P  .001). Most
of the “V first” (48.9%) were performed by surgeon B,
while most of the “A first” (56.9%) were performed by
surgeon A. The group of “other” surgeons that were desig-
TABLE 1. Demographics and tumor-related variables
Variable
Total V-first A-first
P valueNo % No % No %
Total 279 100 133 100 146 100
Age (mean  SD) 65.1  10 64.5  10 65.7  10 NS
Gender
Male 175 62.7 86 64.7 89 61 NS
Female 104 37.3 47 35.3 57 39
Positive history of smoking 217 77.7 109 82 108 74.5 NS
Previous malignancies*
Yes 38 13.7 17 12.9 21 14.4 NS
No 240 88.3 115 87.1 125 85.6
Histology
Squamous cell 83 29.7 44 33.1 39 26.7 NS
Adenocarcinoma† 151 54.1 63 47.4 88 60.3
Large cell 19 6.8 9 6.8 10 6.8
Bronchoalveolar 13 4.7 9 6.8 4 2.7
Others 13 4.7 8 6 5 3.5
Grade
Well diff. 58 20.9 29 21.8 29 19.9 NS
Well to mod diff. 23 8.3 12 9 11 7.5
Mod diff. 62 22.4 33 24.8 29 19.9
Mod to poor 13 4.7 1 0.8 12 8.2
Poorly diff. 75 27.1 41 30.8 34 23.3
Unknown 48 17.2 17 12.8 31 21.2
Stage
I 152 54.5 77 57.9 75 51.4 NS
II 50 17.9 21 15.8 29 19.9
III 68 24.4 29 21.8 39 26.7
IV 9 3.2 6 4.5 3 2.1
*Missing data for one patient from the “V-first.”
†Adenocarcinoma vs. all other histological types, P  .04.
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nated as C used both methods of interruption in similar
rates.
Postoperative complications were present in 32% of the
study population with no significant differences, technical
or other, between the groups. The mean hospital stay was
9.51 days (4.98) for the A-first group and 8.88 days
(4.93) for the V-first group. This also was without signif-
icant difference between the groups.
Follow-up and Recurrence
Total disease recurrence rate was 52.3%, 78 patients (53%)
of the A-first group and 68 patients (51%) of the V-first
group (P  .7).
Risk factors for recurrence of disease (Table 3) were:
male sex (P  .01), high stage of disease (P  .0001),
incomplete resection (P  .0001), blood transfusion (P 
.006), and lung manipulation (P  .006).
Significant association was found between stage of dis-
ease and performance of complete resection; although 93%
of patients in stages I to II underwent complete resection,
this was achieved in only about 50% of patients in higher
stages (P  .0001). Therefore, these 2 parameters could not
be included in the same model.
Table 4 presents 4 separate models of analysis, where the
variable under investigation was retained in the models, and
the other variables that emerged as significant in the uni-
variate analysis were entered gradually. Stage of disease
showed about threefold increased risk for recurrence, which
remained similar after introducing the influence of the per-
forming surgeon (models 2 and 3). Because the distribution
of sequence of interruption was significantly different be-
tween surgeons, and to rule out possible confounding and/or
modifying effect, we investigated the main effect of surgeon
and its interaction with sequence of interruption. The P
value for the overall effect of surgeon was .09 and the
interaction was not significant (P  .2; not shown).
The fourth model showed elevated risk for recurrence
among patients with high stage of disease (odds ratio [OR]
 2.54, 95% confidence intervals [CI] 1.39-4.65), male
gender (OR  1.59, 95% CI 0.95-2.67), patients who un-
derwent lung manipulation (OR 2.72, 95% CI 0.84-8.81),
and patients who received blood transfusion (OR  1.49,
95% CI 0.82-2.73). None of the models demonstrates evi-
dence that sequence of interruption affected disease recur-
rence (from OR  1.04, P  .9, to OR  1.29, P  .4 in
models 1 and 4, respectively).
TABLE 2. Operative approach characteristics
Variables No. %
V-first A-first
P valueNo. % No. %
Total 279 100 133 100 146 100
Type of resection
Lobectomy alone 213 76.3 104 78.2 109 74.7 NS
Combined resection
Sleeve 16 5.7 11 8.3 5 3.4 NS
Pericard 2 0.7 1 0.8 1 0.7 NS
Wedge 20 7.2 5 3.8 15 10.3 .03
CW, pleura, diaphragm 38 13.6 18 13.5 20 13.7 NS
Side
Left 113 40.6 45 34.1 68 46.6 .03
Right 165 59.3 87 65.9 78 53.4
Complete resection
Yes 226 81 107 80.5 119 81.5 NS
No 53 19 26 19.5 27 18.5
Frozen section
Yes 61 21.9 28 21.1 33 22.6 NS
No 218 78.1 105 78.9 113 77.4
Lung manipulation
Yes 21 7.5 6 4.5 15 10.3 NS
No 258 92.5 127 95.5 131 89.7
Surgeon
A 105 37.6 23 17 82 56.9 .001
B 83 29.7 66 48.9 17 11.8
C* 91 32.6 46 34.1 45 31.3
Blood transfusion 75 27 37 27.8 38 26.6 NS
During surgery 35 12.6 20 15 15 10.4
Following surgery 30 10.8 14 10.5 16 11.1
Both 10 3.6 3 2.3 7 4.9
*C-a group of: all other surgeons.
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The same analyses were performed while replacing stage
of disease by completeness of resection due to the associa-
tion observed between these two variables. Sequence of
interruption remained uninfluential in accordance with the
findings reported in Table 4.
Discussion
Although the assumption that certain manipulations on the
lung during resection for malignancy causing shedding of
tumor cells into the blood stream may eventually cause
metastasis and adversely affect the prognosis makes sense,
it has never been proven by clinical evidence. Moreover, the
sequence of vessel interruption during lobectomy for
NSCLC as an independent prognostic variable was never
examined in an epidemiologic study.
Our main aim in this study was to evaluate the impact
that the sequence of hilar vessel interruption during lobec-
tomy for NSCLC has on prognosis. Our results did not
confirm that the sequence of interruption (artery first versus
vein first) is a risk factor for disease recurrence (OR 1.29,
95% CI 0.73-2.29). The report by Kurusu and associates6 is
the only previous study in the literature that evaluated the
sequence of vessel ligation during lobectomy for NSCLC as
an independent variable for outcome, and indeed found that
TABLE 3. Univariate analysis for disease recurrence
Parameters Categories Total
Disease recurrence
(N  146)
P valueNo. %
Gender female 104 44 42.3
male 175 102 58.3 .01
Age (years) 70 177 90 50.8
70 102 56 54.9 NS
Pathology squamous 83 47 56.6
ACOBAC 151 79 52.3
others 45 20 44.4 NS
Stage I 152 62 40.8
II 50 28 56.0
III 68 49 72.1
IV 9 7 77.8 .0001
Method V-first 133 70 52.6
A-first 146 76 52.1 NS
Complete resection no 53 41 77.4
yes 226 105 46.5 .0001
Side* left 113 60 53.1
right 165 86 52.1 NS
Blood transfusion no 202 95 47.0
yes 77 51 66.2 .006
Previous malignancies* no 240 127 52.9
yes 38 19 50.0 NS
Frozen section no 218 119 54.6
yes 61 27 44.3 NS
Lung manipulation no 258 129 50.0
yes 21 17 81.0 .006
ACOBAC, Adenocarcinoma other than bronchoalveolar type.
*One subject with missing information.
TABLE 4. Multivariate logistic models results for factors influencing recurrence of disease
Variables Categories
I II III IV
CR 95% CI P OR 95% CI P OR 95% CI P OR 95% CI P
Sequence interruption A vs. V 1.04 0.65-1.66 .9 1.02 0.63-1.66 .9 1.32 0.75-2.32 .3 1.29 0.73-2.29 .4
Stage III-IV vs. I-II 3.32 1.87-5.89 .001 3.06 1.71-5.47 .001 2.54 1.39-4.65 .003
Surgeon Overall effect .09 .13
Lung manipulation Yes vs. No 2.72 0.84-8.81 .1
Blood transfusion Yes vs. No 1.49 0.82-2.73 .2
Gender M vs. F 1.59 0.95-2.67 .08
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it is a predictor for tumor cell spread in the circulation. They
examined the presence of a peripheral epithelial marker
(carcinoembryotic antigen messenger ribonucleic acid) in
the circulation before, during, and after lobectomy in 30
patients with NSCLC. Each patient was randomly assigned
to have either lobar vein interruption or lobar artery inter-
ruption first. Nine of the 14 patients with preoperative
negative test results became positive during the operation.
Such conversion was more common with arterial interrup-
tion first than with vein interruption first (6/7 versus 3/7
patients). They concluded that ligation of the pulmonary
vein before ligating the artery may lessen intraoperative
hematogenous dissemination. In another similar study by
this group,8 using the same peripheral marker, VATS lo-
bectomy was compared with open lobectomy. The authors
found that VATS lobectomy was associated with a higher
risk of seeding of tumor cells into the circulation during
operation. This phenomenon was suggested to be related to
a more frequent and forceful retraction and manipulation of
the diseased lobe to attain better fields of vision during
VATS lobectomy. However, no survival or recurrence rate
data were available for the patients in both studies. The
presence of circulating tumor cells is an indirect parameter
for metastatic spread and does not necessarily predict the
subsequent appearance of clinical metastatic disease. The
clinical significance of the findings in these 2 studies re-
mains unclear.
Although the main goal of the present study was to
determine the significance of the sequence of vessel inter-
ruption, we evaluated multiple factors. In most multivariate
analyses for operated patients, stage of disease and perfor-
mance status were found to be the most important prognos-
tic factors for survival.1,10-12 In our study, stage of disease
emerged as the strongest risk factor for disease recurrence
(OR  2.54, 95% CI 1.39-4.65). Because performance
status was not specified in all charts it was not included as
a variable in our model. Incomplete resection highly corre-
lated with stage in our analysis and was found to be strong
prognostic risk factor for recurrence. The prognosis and
management of an incompletely resected NSCLC is some-
what disputed in the current surgical literature, resulting
mainly from differences in terminology. Traditionally, mac-
roscopic or microscopic residual disease at the resection
margin has been designated as incomplete resection, but
many investigators include also the presence of tumor in the
highest mediastinal node sampled.13 Lacasse and col-
leagues14 studied incomplete resection in NSCLC using the
broader definition in a logistic regression model for disease
recurrence or death, and did not find it to be a prognostica-
tor.
Other risk factors that showed borderline significant ev-
idence in this study for disease recurrence were: male gen-
der (P  .08) and lung manipulation (P  .1). The per-
forming surgeon had some influence although with
borderline significance (P  .13). Our finding of a lower
risk for recurrence among women is in accordance with the
literature, where female sex was associated with signifi-
cantly longer survival15 and event-free survival.16
Blood transfusion also showed excess risk for recurrence
(OR 1.49, 95% CI 0.82-2.73). This issue was discussed in
previous reports and a dispute exists about the impact of
perioperative blood transfusion on patient prognosis.17-19
Our finding with regard to the nil effect of a previous
malignancy on the outcome is in accordance with other
studies.20-22
The inclusion of frozen section and lung manipulation in
our analysis mandates explanation. We believe that while
waiting for the frozen section result, the surgeon might have
continued with hilar dissection and fissure division. In this
case the sequence of interruption would not considerably
affect tumor dissemination as it could have occurred before
the vessels were addressed. This variable was similarly
distributed between the 2 study groups and also did not
affect recurrence rate. Inclusion of lung manipulation in the
analysis had a similar rationale, as manipulations and force-
ful retraction of the lung prior to vessel interruption could
cause more tumor cell dissemination than the lobectomy
itself. Our results confirmed that lung manipulation is a risk
factor for recurrence.
Three operative variables analyzed in the current study
(ie, lung manipulation, interruption of the pulmonay artery
first, and frozen section examination) share a common fea-
ture (ie, the increased risk of disseminating tumor cells into
the circulation). The first 2 were proven by clinical or
laboratory studies as discussed earlier5,6 to increase the
presence of malignant cells in peripheral blood. Whether
this phenomenon also increases the hazard for metastatic
spread is yet to be determined. The process of metastatic
formation depends on a myriad of host, tumor, and tumor-
host relationship factors. Malignant cells are constantly
shed from primary tumors into the blood stream. The ma-
jority of them are consumed by circulating macrophages23
and only a minority would complete the sequence of events
required to cross the endothelium. Most of the later are
destroyed by tissue defense mechanisms. Only 1:10,000
circulating malignant cells eventually creates a metastasis.23
Increased shedding of tumor cells into the circulation was
demonstrated in breast cancer during surgery,24 fine needle
aspiration biopsy,25 resection of hepatic metastases of colo-
rectal carcinoma,26 and brachytherapy for prostatic can-
cer.27 Hayashi and colleagues28 showed that no-touch iso-
lation techniques may lower shedding of malignant cells
into the portal vein during colorectal resection. Unfortu-
nately, none of these studies sought prognostic correlations.
Thus, similar to NSCLC, the clinical importance of tumor
cell dissemination during various manipulation is still a
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puzzle. Resembling but not identical to vascular dissemina-
tion is the phenomenon of a positive pleural lavage cytology
in patients undergoing resection for NSCLC and presenting
without pleural spread. Some investigators29,30 have shown
that this is associated with a poor prognosis. In our retro-
spective study we have shown that lung manipulation is
associated with a worse outcome, although interruption of
the pulmonary artery first and frozen section are not. The
impact of tumor manipulation (including sequence of inter-
ruption and use of frozen section) during surgery on recur-
rence could be determined by a prospective study combin-
ing clinical variables and the detection of circulating tumor
cells.
The role of the operating surgeon on recurrence is one of
the limitations of this study. Evidently, each surgeon is
bound to his own method so that the sequence of interrup-
tion is highly associated with the surgeon performing the
operation. We have tried to cope with this issue by including
the effect of the operating surgeon in the multivariable
analysis. The overall effect of the surgeon was with border-
line significance and the interaction did not seem to alter the
results. Interestingly, a review of the literature revealed that
the majority of the studies that involve surgical therapy
ignore the performer, the surgeon, as a possible prognostic
factor for recurrence or survival. This subject was exten-
sively discussed by Fielding and colleagues,31 who studied
surgical treatment in colorectal cancer and found a wide
range of postoperative mortality rates among 28 different
surgeons. Our findings supported their claim that surgeons
vary in the ability to produce a given result, a phenomena
known as “surgeon related variability.” To overcome this
problem, they suggested listing the predictive variables that
are “surgeon- related” and treating them in the same way
that “patient-related” variables are being treated. In this way
a similarity in the study groups can be achieved or, when
stratification is not possible, to demonstrate when the results
are reported that randomization has succeeded in equally
distributing the variables. Unfortunately, these principles
cannot be fully applied by and large in a retrospective study
and indeed “surgeon-related” variables are hardly evident in
recent studies of any type in respect to prognosis, recur-
rence, or survival in lung cancer. In addition, although in
multicentric clinical trials the large scale of surgeons par-
ticipating in the study increases the variance and the sever-
ity of this problem, it is evident that the small number of
surgeons who participated in our study contributed to the
presented problem. Because each surgeon was bound to his
own method, only a prospective study with randomized
selection of the method for each patient and defining the
“surgeon-related” predictive variables can provide definite
answer to this puzzling issue.
Our results do not support the hypothesis that the se-
quence of vessel interruption during lobectomy for NSCLC
affects disease recurrence. A prospective study with ran-
domized selection of method for each patient is needed to
confirm these results.
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